[1] Reijnierse M, Schwabl C, Klauser A.Imaging of crystal disorders: calcium pyrophosphate dihydrate crystal deposition disease, calcium hydroxyapatite crystal deposition disease and gout pathophysiology, imaging, and diagnosis[J]. Radiol Clin North Am, 2022, 60(4): 641-656. [2] Meng J, Guo C, Luo H, et al.A case of destructive calcium pyrophosphate dihydrate crystal deposition diseaseof the temporomandibular joint: a diagnostic challenge[J]. Int J Oral Maxillofac Surg, 2011, 40(12): 1431-1437. [3] Kudoh K, Kudoh T, Tsuru K, et al.A case of tophaceous pseudogout of the temporomandibular joint extending to the base of the skull[J]. Int J Oral Maxillofac Surg, 2017, 46(3): 355-359. [4] Zhang W, Doherty M, Pascual E, et al.EULAR recommendations for calcium pyrophosphate deposition. Part II: management[J]. Ann Rheum Dis, 2011, 70(4): 571-575. [5] 尹海波, 徐瑾, 王瑞琳, 等. 二水焦磷酸钙结晶沉积症60例临床病理分析[J]. 临床与实验病理学杂志, 2016, 32(11): 1267-1269. Yin HB, Xu J, Wang RL, et al.A clinicopathological analysis of 60 cases of calcium pyrophosphate dihydrate crystallization deposition[J]. Chinese Journal of Clinical and Experimental Pathology, 2016, 32(11): 1267-1269. [6] Mikami T, Takeda Y, Ohira A, et al.Tumoral calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint: identification on crystallography[J]. Pathol Int, 2008, 58(11): 723-729. [7] Pendleton A, Johnson MD, Hughes A, et al.Mutations in ANKH cause chondrocalcinosis[J]. Am J Hum Genet, 2002,71(4):933-940. [8] Zhang Y, Johnson K, Russell RG, et al.Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5'-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate[J]. Arthritis Rheum, 2005, 52(4): 1110-1117. [9] Jubeck B, Gohr C, Fahey M, et al.Promotion of articular cartilage matrix vesiclemineralization by type Ⅰ collagen[J]. Arthritis Rheum, 2008, 58(9): 2809-2817. [10] Kalya S, Rosenthal AK.Extracellular matrix changes regulate calcium crystal formation in articular cartilage[J]. Curr Opin Rheumatol, 2005, 17(3): 325-329. [11] Abhishek A, Doherty M.Epidemiology of calcium pyrophosphate crystal arthritis and basic calcium phosphate crystal arthropathy[J]. Rheum Dis Clin North Am, 2014, 40(2): 177-191. [12] Matsumura M, Hara S.Images in clinical medicine. crowned dens syndrome[J]. N Engl J Med, 2012, 367(23): e34. [13] Miksanek J, Rosenthal AK.Imaging of calcium pyrophosphate deposition disease[J]. Curr Rheumatol Rep, 2015,17(3): 20-30. [14] Terauchi M, Uo M, Fukawa Y, et al.Chemical diagnosis of calcium pyrophosphate deposition disease of the temporomandibular joint: a case report[J]. Diagnostics (Basel), 2022, 12(3): 651-660. [15] Naqvi AH, Abraham JL, Kellman RM, et al.Calcium pyrophosphate dihydrate deposition disease (CPPD)/pseudogout of the temporomandibular joint-FNA findings and microanalysis[J]. Cytojournal, 2008,5(1): 8-13. [16] Shidham V, Chivukula M, Basir Z, et al.Evaluation of crystals in formalin-fixed, paraffin-embedded tissue sections for the differential diagnosis of pseudogout, gout, and tumoral calcinosis[J]. Mod Pathol, 2001,14(8): 806-810. [17] Reynolds JL, Matthew IR, Chalmers A.Tophaceous calcium pyrophosphate dihydrate deposition disease of the temporomandibular joint[J]. J Rheumatol, 2008, 35(4): 717-721. [18] 李亚法, 王双义, 于晓宁. 颌面部焦磷酸钙沉积病并文献复习[J]. 海南医学, 2016, 27(23): 3946-3947. Li YF, Wang SY, Yu XN.Maxillofacial calcium pyrophosphate deposition disease and literature review[J].Hainan Medical Journal, 2016, 27(23): 3946-3947. [19] Richette P, Bardin T.Calcium pyrophosphate deposition disease[J]. Presse Med, 2011,40(9 Pt 1): 856-864. [20] So PP, Tsui FW, Vieth R, et al.Inhibition of alkaline phosphatase by cysteine: implications for calcium pyrophosphate dihydrate crystal deposition disease[J]. J Rheumatol, 2007,34(6): 1313-1322. |